Pediatric Liver Transplant Recipients with Food Allergy Show Profound T-cell Activation and Elevated Inflammatory Cytokines
Background
Pediatric liver transplantation (LT) significantly improves survival for end-stage liver disease, but recipients face unique post-transplant complications. One such challenge is an increased susceptibility to food allergy, termed liver transplantation-associated food allergy (LTFA), whose underlying immune mechanisms remain poorly understood. Current understanding of post-transplant immune dysregulation often focuses on preventing rejection, yet less is known about its role in allergic sensitization. Identifying specific immune profiles could offer insights into LTFA pathogenesis and potential therapeutic targets beyond standard immunosuppression.
Study Design
This cross-sectional cohort study evaluated circulating T- and B-cell subsets and serum cytokine profiles in 43 pediatric LT recipients, of whom 8 had LTFA. For comparison, nontransplanted food allergic controls and healthy controls were also recruited. T- and B-lymphocyte subsets were analyzed using flow cytometry, while serum concentrations of 15 cytokines were measured. The primary objective was to identify distinct immune signatures associated with LTFA development in this vulnerable population.
Results
Children diagnosed with LTFA exhibited significantly increased proportions of newly activated CD69+ T cells within both CD4+ and CD8+ subsets (P = 0.001 and P < 0.001, respectively), compared to LT recipients without LTFA. They also showed a higher proportion of CD4+ T cells with the effector memory CD45RA+ phenotype (P = 0.001). Furthermore, LTFA patients had elevated serum levels of the T helper 2 cytokine interleukin-4 (P = 0.004) and the pro-inflammatory cytokines tumor necrosis factor-alpha (P = 0.007) and tumor necrosis factor-beta (P = 0.03). This broad immune activation was not observed in the nontransplanted food allergic control group, suggesting a transplant-specific immune context.
Notably, the entire cohort of LT recipients, irrespective of food allergy status, displayed significantly larger proportions of activated, memory, effector, and effector memory
CD45RA+subsets of bothCD4+andCD8+T cells, alongside higher levels of all 15 measured cytokines, when compared to age- and sex-matched healthy controls.
Key Findings
- LTFA children had increased newly activated
CD69+T cells (CD4+ P=0.001, CD8+ P<0.001). - LTFA children showed higher
CD4+effector memoryCD45RA+T cells (P=0.001). - Serum
IL-4was elevated in LTFA children (P=0.004). - Pro-inflammatory
TNF-alpha(P=0.007) andTNF-beta(P=0.03) were higher in LTFA children. - All LT recipients showed broad T-cell activation and elevated cytokines compared to healthy controls.
Why It Matters
This study highlights a pervasive state of immune activation in pediatric liver transplant recipients, which is particularly pronounced in those who develop food allergies. Understanding this distinct immune profile could pave the way for early identification of LTFA risk and potentially inform targeted immunomodulatory strategies. For clinicians, these findings suggest that monitoring specific T-cell activation markers and cytokine levels might serve as prognostic indicators for LTFA. While this is an observational study, it provides crucial mechanistic insights into why some transplant recipients develop allergies, differentiating their immune response from general food allergy. Future research could explore whether specific immunosuppressive regimens or adjunctive therapies could mitigate this immune activation and reduce LTFA incidence.
liver-transplantation
food-allergy
pediatric
t-cell-activation
cytokines
immune-dysregulation